A commission may be earned through links in this article at no additional cost to you
The major cardiovascular safety trials The SUSTAIN-6 trial enrolled 3,297 patients with type 2 diabetes and high cardiovascular risk, following them for two years on semaglutide 0.5 mg or 1.0 mg weekly versus placebo
Research Applications MT-1 has been utilized as a molecular probe in controlled experimental systems examining: Melanocortin receptor pharmacology (MC1R, MC3R, MC4R, MC5R) Melanogenesis and pigmentation signaling pathways UV-induced DNA damage and nucleotide excision repair models Cutaneous photoprotection biology Skin inflammatory signaling and cytokine modulation Oxidative stress responses in melanocytes and keratinocytes Erythropoietic protoporphyria (EPP) photoprotection models
Medications like Invokana block SGLT2, causing more glucose to leave the body through urine rather than being reabsorbed
Cabin pressure, reduced oxygen, and the general discomfort of sitting in a cramped seat for hours can all amplify gastrointestinal symptoms